Skip to content

4/AAccepted Jun 2, 9:46 AM ET

Javitt Jonathan C 4/A

NRXPNRX Pharmaceuticals, Inc.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

9:46 AM

Jun 2, 2022

Filed

Jun 2, 2022

Documents

1

Size

6.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.